 The Role of Residual Symptoms in Nonadherence to Treatment (22 Minutes)
Faculty: By Richard C. Shelton, MD
This CME Expert Review PsychCast™ is jointly sponsored by the Mount Sinai School of Medicine and MBL Communications.
Release Date: April 30, 2010
Termination Date: April 30, 2012
Estimated time to complete this activity: 15 minutes
Medium: The content is delivered by PsychCast™ with a PDF or web-based Posttest
Acknowledgment of Commercial Support: Funding for this activity has been provided by an educational grant from Eli Lilly and Company
Activity Review Information: The content has been peer reviewed and approved by Susan F. Abbott, MD. Review Date: November 12, 2009.
Faculty Affiliation
Richard C. Shelton, MD, is James G. Blakemore Research Professor and Vice Chair for Clinical Research in the Department of Psychiatry at Vanderbilt University School of Medicine in Nashville.
CME Course Director James C.-Y. Chou, MD, is associate professor of psychiatry at Mount Sinai School of Medicine in New York City.
Susan F. Abbott, MD, is assistant professor of psychiatry in the Division of Child and Adolescent Psychiatry at Mount Sinai School of Medicine, and Chief of Child and Adolescent Inpatient Psychiatry Units at Mount Sinai Medical Center in New York City.
Faculty Disclosure Policy Statement
It is the policy of the Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.
Faculty Disclosure
Dr. Shelton is a consultant to and serves on the advisory boards of Forest, Janssen, the National Institute of Mental Health, Novartis, Otsuka, Pamlab, and Repligen; and has received grant/research support from Bristol-Myers Squibb, Eli Lilly, Forest, Janssen, the National Institute of Mental Health, Novartis, Otsuka, Pamlab, Pfizer, and Repligen.
Dr. Chou has received honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, and Pfizer.
Dr. Abbott reports no affiliation with or financial interest in any organization that may pose a conflict of interest.
Learning Objectives
At the completion of this activity, participants should be better able to:
• Recognize the scope of patient nonadherence to antidepressant therapy and its effect on patient outcomes
Target Audience: This activity is designed to meet the educational needs of psychiatrists and primary care physicians.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: The Mount Sinai School of Medicine designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclaimer: These are the opinions of the authors not of the sponsors or supporters. For more information, contact MBL Communications at cme@mblcommunications.com.
Minimum Hardware/Software Requirements
Macintosh: PowerPC processor, Mac OS 8.6, 9.0.4, 9.1, or Mac OS X, 64MB of RAM, 24MB of available hard-disk space, and Safari 1.x or 2.x.
Windows PC: Intel Pentium processor, Microsoft Windows 95 OSR 2.0, Windows 98 and 98 SE, Windows Millennium Edition, Windows NT 4.0 with Service Pack 5, Windows 2000, or Windows XP, 64MB of RAM, 24MB of available hard-disk space, and Internet Explorer 6.x and newer or Firefox 1.x and newer.
This CME Activity and Posttest information file is a PDF (Portable Document Format) document. To view this file, you will need Adobe Acrobat Reader, which is available free at www.adobe.com. Follow the instructions on that page to download and install the software.
The Role of Residual Symptoms in Nonadherence to Treatment
(22 Minutes)
Faculty: Richard C. Shelton, MD
Abstract
It is estimated that 15 million Americans have a depressive disorder, including major depressive disorder, and many of those afflicted do not receive recommended guideline levels of care. Of patients who are correctly diagnosed with depression, a majority of patients do not recover by 4–6 months, often due to discontinuing treatment prior to the initiation of therapeutic effect. It is important for clinicians to understand the factors involved in nonadherence to treatment for the depressive disorders, including presence of residual symptoms, younger age, and less educational attainment. Once clinicians believe a patient is at risk for nonadherence—which is the rule rather than the exception—health care professionals have various techniques available to increase treatment adherence, including communication techniques and other health care interventions.
In this Expert Review PsychCast™, Richard C. Shelton, MD, reviews data from the Sequenced Treatment Alternatives to Relieve Depression study to determine the role residual depressive symptoms have in causing patients to become nonadherent to treatment as well as defines characteristics common to patients who discontinue their medications.
To receive credit for this activity: Listen to the PsychCast™, reflect on the material presented, and complete the online CME Posttest/Evaluation here or to submit the CME Posttest/Evaluation by mail or fax, download a PDF here. To obtain credit, you should score 70% or better. The estimated time to complete the PsychCast™ and the posttest and evaluation is 15 minutes. Successful completion of the posttest and evaluation will allow you to claim credit and print a certificate.
Early submission of this posttest is encouraged: please submit by April 1, 2012 to be eligible for credit. If you have any questions, please e-mail cme@mblcommunications.com.
Read the extended CME supplement related to this PsychCast™ activity here
|
Subscribe |
Download |
|
|
|
|
